Collaboration Details

Print  Close

Title of Collaborative Activity:

FDA /Cancer Diagnosis Program (CDP) monthly meeting

Description of Collaborative Activity:

Participants discuss proposed integral markers and process for regulatory input into integral markers/assays for clinical trials.

Type of Collaborative Activity:

Select Type of Collaborative Activity

Year the Collaborative Activity Originated:


NIH Participating Institutes/Centers/Office of the Director:


HHS Agency Collaborators on this Activity: